参考文献/References:
[1]高戈,冯喆,常志刚,等.2012国际脓毒症及脓毒性休克诊疗指南[J].中华危重病急救医学,2013,25(8):501-505.
[2]王帅.乌司他丁对重症脓毒症患者凝血功能影响的临床研究[J].中国实用医药,2013,8(21):185-186.
[3]陈炜,赵磊,牛素平,等.不同炎症因子对细菌性血流感染所致脓毒症患者的早期诊断价值[J].中华危重病急救医学,2014,26(3):165-170.
[4]张赤,罗华,张声,等.血必净、乌司他丁联合治疗脓毒症时对凝血机制的影响[J].内科急危重症杂志,2015,16(3):145-147.
[5]茅尧生,吕铁,孟东亮,等.血必净联合乌司他丁对重症脓毒症的疗效及作用机制的研究[J].中国急救医学,2014,12(28):1077-1080.
相似文献/References:
[1]赵建美,邵 岩.血必净治疗社区获得性肺炎的研究进展[J].医学信息,2018,31(02):20.[doi:10.3969/j.issn.1006-1959.2018.02.009]
ZHAO Jian-mei,SHAO Yan.Research Progress of Xuebijing in Treating Community Acquired Pneumonia[J].Journal of Medical Information,2018,31(04):20.[doi:10.3969/j.issn.1006-1959.2018.02.009]
[2]甘维桃,曾 凡,冮绍斌.乌司他丁对膝关节置换术后关节炎症及周围肿胀的影响[J].医学信息,2019,32(02):161.[doi:10.3969/j.issn.1006-1959.2019.02.049]
GAN Wei-tao,ZENG Fan,GANG Shao-bin.Effect of Ulinastatin on Joint Inflammation and Peripheral Swelling after Knee Joint Replacement[J].Journal of Medical Information,2019,32(04):161.[doi:10.3969/j.issn.1006-1959.2019.02.049]
[3]刘 云,于洪波.乌司他丁与生长抑素治疗重症急性胰腺炎临床疗效观察[J].医学信息,2019,32(01):160.[doi:10.3969/j.issn.1006-1959.2019.01.050]
LIU Yun,YU Hong-bo.Clinical Efficacy of Ulinastatin and Somatostatin in the Treatment of Severe Acute Pancreatitis[J].Journal of Medical Information,2019,32(04):160.[doi:10.3969/j.issn.1006-1959.2019.01.050]
[4]杨巧侠,王成果,王元欣.乌司他丁预处理对HepG2细胞氧化损伤保护作用的研究[J].医学信息,2019,32(13):72.[doi:10.3969/j.issn.1006-1959.2019.13.020]
YANG Qiao-xia,WANG Cheng-guo,WANG Yuan-xin.Protective Effect of Ulinastatin Pretreatment on Oxidative Damage in HepG2 Cells[J].Journal of Medical Information,2019,32(04):72.[doi:10.3969/j.issn.1006-1959.2019.13.020]
[5]魏一鸣.乌司他丁对体外循环二尖瓣置换术患者肺功能损伤及炎性因子的影响[J].医学信息,2020,33(09):142.[doi:10.3969/j.issn.1006-1959.2020.09.046]
WEI Yi-ming.Effect of Ulinastatin on Lung Function Injury and Inflammatory Factors in Patients Undergoing Mitral Valve Replacement with Cardiopulmonary Bypass[J].Journal of Medical Information,2020,33(04):142.[doi:10.3969/j.issn.1006-1959.2020.09.046]
[6]张 姝.血必净联合激素在脓毒血症急诊处理中的疗效研究[J].医学信息,2022,35(19):89.[doi:10.3969/j.issn.1006-1959.2022.19.024]
ZHANG Shu.Study on Curative Effect of Xuebijing Combined with Hormone in Emergency Treatment of Sepsis[J].Journal of Medical Information,2022,35(04):89.[doi:10.3969/j.issn.1006-1959.2022.19.024]
[7]王镜媛,寿松涛.血必净联合胸腺肽α1治疗重症肺炎合并脓毒症的效果[J].医学信息,2020,33(16):169.[doi:10.3969/j.issn.1006-1959.2020.16.056]
WANG Jing-yuan,SHOU Song-tao.The Effect of Xuebijing Combined with Thymosin α1 in the Treatment of Severe Pneumonia Complicated with Sepsis[J].Journal of Medical Information,2020,33(04):169.[doi:10.3969/j.issn.1006-1959.2020.16.056]
[8]邓 伟.血必净注射液预防STEMI患者直接介入治疗后冠脉无复流的效果[J].医学信息,2020,33(17):163.[doi:10.3969/j.issn.1006-1959.2020.17.049]
DENG Wei.Effect of Xuebijing Injection in Preventing Coronary Artery No-reflow After Direct Interventional Therapy in STEMI Patients[J].Journal of Medical Information,2020,33(04):163.[doi:10.3969/j.issn.1006-1959.2020.17.049]
[9]隋文峰,马海英,潘 雪.乌司他丁联合头孢哌酮钠舒巴坦钠注射剂治疗重症肺部感染的疗效[J].医学信息,2020,33(19):143.[doi:10.3969/j.issn.1006-1959.2020.19.044]
SUI Wen-feng,MA Hai-ying,PAN Xue.The Efficacy of Ulinastatin Combined with Cefoperazone Sodium and Sulbactam Sodium Injection in the Treatment of Severe Pulmonary Infection[J].Journal of Medical Information,2020,33(04):143.[doi:10.3969/j.issn.1006-1959.2020.19.044]
[10]王 凯,田国栋.连续血液净化联合血必净对ARDS患者氧化应激、APACHEⅡ评分的影响[J].医学信息,2021,34(22):130.[doi:10.3969/j.issn.1006-1959.2021.22.040]
WANG Kai,TIAN Guo-dong.Effect of Continuous Blood Purification Combined with Xuebijing on Oxidative Stress and APACHEⅡ Score in ARDS Patients[J].Journal of Medical Information,2021,34(04):130.[doi:10.3969/j.issn.1006-1959.2021.22.040]